This inventor holds 52 USPTO granted patents and 23 published patent applications, plus 22 CIPO patents and 25 EPO patents, primarily in Ophthalmic Lenses. Top assignees: Alcon, Inc., Novartis Ag, Alcon Manufacturing, Ltd.. Active years: 2008-2025.
Location History:
- Arlington, TX (US) (2008 - 2014)
- Fort Worth, TX (US) (2011 - 2024)
Company Filing History:
26 out of 1,295 
25 out of 3,973 
1 out of 81 Years Active: 2008-2025
Areas of Expertise:
Title: Innovator Xin Hong: Pioneering Multifocal Lens Technologies
Introduction: Xin Hong, based in Fort Worth, TX, is an accomplished inventor with an impressive portfolio of 47 patents. His work primarily focuses on advancements in ophthalmic devices, particularly multifocal lenses that aim to improve visual clarity and comfort for users.
Latest Patents: Among Xin's most recent innovations are two notable patents: the "Multifocal Lens Having Reduced Visual Disturbances" and the "Multifocal Ophthalmic Lens Having Chromatic Aberration Correction". The first patent describes a sophisticated ophthalmic device featuring an ophthalmic lens designed with both anterior and posterior surfaces, alongside a diffractive structure and specific base curvatures. This design allows for differing spherical aberrations at distinct focal lengths, ultimately enhancing the visual experience by minimizing disturbances across various distances.
The second patent entails an ophthalmic lens that integrates a unique combination of surface profiles, including a base curvature, a refractive region, and a diffractive profile. This innovation is specially crafted to address longitudinal chromatic aberrations, ensuring clearer vision through its multiple foci.
Career Highlights: Xin Hong has significantly contributed to the fields of ophthalmology and optometry throughout his career, especially during his tenure at leading companies like Novartis AG and Alcon, Inc. His expertise in lens design has played a crucial role in developing cutting-edge optical solutions that improve patient outcomes and visual performance.
Collaborations: Throughout his career, Xin has worked alongside esteemed colleagues, including Xiaoxiao Zhang and Mutlu Karakelle. These collaborations have fostered a dynamic exchange of ideas, leading to innovative breakthroughs in the design and functionality of ophthalmic devices.
Conclusion: Xin Hong continues to be a pivotal figure in the field of ophthalmology through his extensive patent portfolio and innovative contributions. His work not only reflects his dedication to advancing visual technologies but also highlights the collaborative spirit that drives success in the research and development of groundbreaking inventions. As he continues to push the boundaries of ophthalmic device technology, Xin's influence in the industry remains significant and inspiring.